scispace - formally typeset
J

Julien Kirchgesner

Researcher at University of Paris

Publications -  69
Citations -  2210

Julien Kirchgesner is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 44 publications receiving 1204 citations. Previous affiliations of Julien Kirchgesner include Brigham and Women's Hospital & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

TL;DR: Among adults with IBD, the use of thiopurine monotherapy or anti-TNF monotherapy was associated with a small but statistically significant increased risk of lymphoma compared with exposure to neither medication, and this risk was higher with combination therapy than with each of these treatments used alone.
Journal ArticleDOI

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

TL;DR: Heterogeneity in risks of serious and opportunistic infections in patients treated with immune-suppressive regimens should be carefully considered and weighed against potential benefits for IBD treatment in patient management.
Journal ArticleDOI

Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study

TL;DR: Patients with IBD are at increased risk of acute arterial events, with the highest risk in young patients, and disease activity may also have an independent impact on the risk.